|
Home
|
E-Submission
|
Sitemap
|
Editorial Office
|
Aims and Scope
About the Journal
Editorial Board
Open Access
Article Processing Charge
Editorial Office
Instructions for Authors
Research and Publication Ethics
Checklist
E-Submission
Copyright Transfer Agreement
Journal Archive
Accepted Articles
Epub Ahead-of Print Articles
Current Issue
Most Read Articles
Most Cited Articles
Cancer Research and Treatment
Search
Author Index
Cancer Research and Treatment
Search
> Browse Articles > Search
Clinical and Genetic Characteristics of
BRCA1/2
Mutation in Korean Ovarian Cancer Patients: A Multicenter Study and Literature Review
Byung Su Kwon, Jung Mi Byun, Hyun Joo Lee, Dae Hoon Jeong, Tae Hwa Lee, Kyung-Hwa Shin, Dong Soo Suh, Ki Hyung Kim
Cancer Res Treat.
2019;51(3):941-950. Published online October 8, 2018 DOI:
https://doi.org/10.4143/crt.2018.312
Cited By 2
Different Patterns of Risk Reducing Decisions in Affected or Unaffected BRCA Pathogenic Variant Carriers
Eun-Gyeong Lee, Hyok Jo Kang, Myong Cheol Lim, Boyoung Park, Soo Jin Park, So-Youn Jung, Seeyoun Lee, Han-Sung Kang, Sang-Yoon Park, Boram Park, Jungnam Joo, Jai Hong Han, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2019;51(1):280-288. Published online May 4, 2018 DOI:
https://doi.org/10.4143/crt.2018.079
Cited By 1
Comparison of Ion Personal Genome Machine Platforms for the Detection of Variants in
BRCA1
and
BRCA2
Sang Mee Hwang, Ki Chan Lee, Min Seob Lee, Kyoung Un Park
Cancer Res Treat.
2018;50(1):255-264. Published online April 7, 2017 DOI:
https://doi.org/10.4143/crt.2017.062
Identification of a Novel
BRCA1
Pathogenic Mutation in Korean Patients Following Reclassification of
BRCA1
and
BRCA2
Variants According to the ACMG Standards and Guidelines Using Relevant Ethnic Controls
Ji Soo Park, Eun Ji Nam, Hyung Seok Park, Jung Woo Han, Jung-Yun Lee, Jieun Kim, Tae Il Kim, Seung-Tae Lee
Cancer Res Treat.
2017;49(4):1012-1021. Published online January 17, 2017 DOI:
https://doi.org/10.4143/crt.2016.433
Cited By 16
Clinically Significant Unclassified Variants in
BRCA1
and
BRCA2
Genes among Korean Breast Cancer Patients
Kyong-Ah Yoon, Boyoung Park, Byung Il Lee, Moon Jung Yang, Sun-Young Kong, Eun Sook Lee
Cancer Res Treat.
2017;49(3):627-634. Published online September 13, 2016 DOI:
https://doi.org/10.4143/crt.2016.292
Cited By 8
Comparison of Clinical Outcomes of
BRCA1/2
Pathologic Mutation, Variants of Unknown Significance, or Wild Type Epithelial Ovarian Cancer Patients
Kyung Jin Eoh, Hyung Seok Park, Ji Soo Park, Seung-Tae Lee, Jeongwoo Han, Jung-Yun Lee, Sang Wun Kim, Sunghoon Kim, Young Tae Kim, Eun Ji Nam
Cancer Res Treat.
2017;49(2):408-415. Published online July 27, 2016 DOI:
https://doi.org/10.4143/crt.2016.135
Cited By 15
Analysis of
BRIP1
Variants among Korean Patients with
BRCA1/2
Mutation-Negative High-Risk Breast Cancer
Haeyoung Kim, Dae-Yeon Cho, Doo Ho Choi, Gee Hue Jung, Inkyung Shin, Won Park, Seung Jae Huh, Seok Jin Nam, Jeong Eon Lee, Won Ho Gil, Seok Won Kim
Cancer Res Treat.
2016;48(3):955-961. Published online January 19, 2016 DOI:
https://doi.org/10.4143/crt.2015.191
Cited By 5
Germline Mutation of
BRCA2
Gene in Korean Breast / Ovarian Cancer Families
Yong Jin Won, Jae Hwan Oh, Ji Hyun Kim, Dong Young Noh, Kuk Jin Choe, Soon Beom Kang, Lee Su Kim, Man Su Ro, Nam Sun Paik, Dae Hyun Yang, Se Min Oh, Soon Nam Lee, Kyung Kook Kim, Jae Gahb Park
J Korean Cancer Assoc.
1998;30(2):242-252.
1